CVE-2025-36226: IBM Aspera Faspex 5 · Cross-site Scripting
Affects IBM Aspera Faspex 5Source CVE Database V5
Not known to be exploited · CVSS 5.4 Medium.
Data as of 30 Oct 2026, 11:52 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 12% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:NExploitation evidence
Disclosed: evidence found.
CVE published 10 Mar 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 30 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| IBMAspera Faspex 5 | Affected
| Fixed in– |
CPE configurations (2)
cpe:2.3:a:ibm:aspera_faspex_5:5.0.0:*:*:*:*:*:*:*cpe:2.3:a:ibm:aspera_faspex_5:5.0.14.3:*:*:*:*:*:*:*
AI-suggested
To mitigate CVE-2025-36226, organizations should first monitor IBM’s official channels for patches and apply them promptly once available. In the interim, implement strict input validation and output encoding on all user-supplied data within the Faspex web UI to prevent script injection. Restrict user permissions to the minimum necessary to reduce the risk of malicious script injection by authenticated users. Employ Content Security Policy (CSP) headers to limit the execution of unauthorized scripts in the browser. Regularly audit user accounts and session management to detect anomalous behavior. Consider isolating Faspex instances behind web application firewalls (WAFs) configured to detect and block XSS payloads. Educate users about phishing and social engineering risks that could lead to credential compromise. Finally, conduct security testing and code reviews focused on input handling in the affected application components.
Description
IBM Aspera Faspex 5 5.0.0 through 5.0.14.3 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.